- D73.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D73.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D73.1 – other international versions of ICD-10 D73.1 may differ.
ICD-10-CM D73.1 is grouped within Diagnostic Related Group(s):
- 814 Reticuloendothelial and immunity disorders with mcc
- 815 Reticuloendothelial and immunity disorders with cc
- 816 Reticuloendothelial and immunity disorders without cc/mcc
Type 1 Excludes
- neutropenic splenomegaly (D73.81)
- primary splenic neutropenia (D73.81)
- splenitis, splenomegaly in late syphilis (A52.79)
- splenitis, splenomegaly in tuberculosis (A18.85)
- splenomegaly NOS (R16.1)
- splenomegaly congenital (Q89.0)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D73.1:
- splenica > Aleukia
- splenic activity > Increase, increased
- myelogenous > Metaplasia
- myeloid (agnogenic) (megakaryocytic) > Metaplasia
- spleen > Metaplasia
- splenic, primary > Panhematopenia D61.9
- big spleen > Syndrome
- hypersplenic > Syndrome